DEVELOPMENT AND OPTIMIZATION OF AN ECONOMIC METHOD FOR QUANTITATION OF AZITHROMYCIN IN HUMAN PLASMA BY TANDEM MASS SPECTROSCOPY (LCMS/MS) FOR CLINICAL TRIALS

Abstract

The present study deals with development and optimization of an economic method for quantitation of Azithromycin in human plasma by Tandem Mass Spectroscopy (LCMS/MS) for Clinical studies. Enalapril (stable and economic) was used as an internal standard. Azithromycin was extracted from plasma using an Oasis HLB solid-phase extraction cartridge (Waters Corporation, USA). The elution was carried out with degassed 0.1% formic acid buffer in methanol (5:95, v/v, economic as compare to commonly used acetonitrile). After elution the elute was evaporated to dryness in nitrogen, and was reconstituted in 100 μl mobile phase (same as elution buffer) and 10 μl of the sample was injected into an HPLC system containing Chromolith RP C18, 100*4.6 mm column connected to LCMS/MS system. The lower limit of quantitation (LLOQ) was 0.95ng/ml, without interfering peaks. The calibration curve was linear (R=0.9979) over a concentration range 0.95ng/ml to 951.63 ng/ml. Retention time for Azithromycin and its internal standard was 1.26 minutes and 1.45 minutes. The accuracy (85%-115%) and precision (CV ≤ 15%) were acceptable. The mean recoveries for Azithromycin at 3, 425 and 875 ng/ml were: 75.44±2.86%, 79.23±4.475% and 74.84±2.86% (n=6), respectively. Azithromycin was stable in plasma for at least 6 hours at room temperature and for at least four freeze and thaw cycles (% change = 3.73 at LOQ and 4.46 at ULQ). It was observed that the method is selective for Azithromycin as no peak interference was observed from plasma matrix while blank plasma or plasma with the drugs was run at RT of internal standard and analyte. The developed method has adequate sensitivity, specificity, accuracy and precision to measure Azithromycin in human plasma and, it can be considered as a cost effective, fast and with the acceptable range of recovery (80% - 90%) for BE studies/clinical trials.

Authors and Affiliations

Snehal Shah* , Rachana

Keywords

Related Articles

PHARMACOEPIDEMIOLOGY AND PHARMACOTHERAPHY OF ARTHRITIS IN NORTH GUJARAT

Several incidence and prevalence studies of RA have been reported during the last decades, suggesting a considerable variation of the disease occurrence among different populations. This epidemiology study has been don...

A SYSTEMATIC REVIEW ON NATURAL MEDICINE USED FOR THERAPY OF DIABETES MELLITUS OF SOME INDIAN MEDICINAL PLANTS

Diabetes mellitus is one of the world’s major diseases. It currently affects an estimated 143 million people worldwide and the number is growing rapidly. In the India, about 1- 5% population suffer from diabetes or rel...

PHYTOSOMES: NOVEL APPROACH FOR DELIVERING HERBAL EXTRACT WITH IMPROVED BIOAVAILABILITY

Plant-derived polyphenols are increasingly gaining attention as dietary supplements for their multidimensional role in homeostatic management of inflammation, to support detoxication, and for anticancer, weight loss, a...

IN VITRO DISSOLUTION ENHANCEMENT OF ALBENDAZOLE BY PREPARATION OF INCLUSION COMPLEXS WITH HP- ß CYCLODEXTRIN

With the introduction of combinatorial chemistry and high throughput screening, the properties of new chemical entities shifted towards higher molecular weight and increasing lipophilicity that results in decreasing aq...

SIMULTANEOUS ESTIMATION OF NEBIVOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE IN BULK AND IN A TABLET DOSAGE FORM BY MULTICOMPONENT AND SIMULTANEOUS ESTIMATION METHOD

Novel, simple, sensitive, rapid, accurate and economical spectrophotometric methods have been developed for simultaneous estimation of Nebivolol Hydrochloride and Hydrochlorothiazide. These methods involve solving of s...

Download PDF file
  • EP ID EP150098
  • DOI -
  • Views 77
  • Downloads 0

How To Cite

Snehal Shah*, Rachana (2010). DEVELOPMENT AND OPTIMIZATION OF AN ECONOMIC METHOD FOR QUANTITATION OF AZITHROMYCIN IN HUMAN PLASMA BY TANDEM MASS SPECTROSCOPY (LCMS/MS) FOR CLINICAL TRIALS. Pharma Science Monitor-An International Journal Pharmaceutical Sciences, 1(2), 58-70. https://europub.co.uk/articles/-A-150098